Background and AimsSeveral artificial intelligence (AI) systems for polyp detection during colonoscopy have emerged in the gastroenterology literature and continue to demonstrate significant improvements in quality outcomes. This study assesses clinical quality outcomes during white-light colonoscopy with and without a novel AI computer-aided detection system, DEtection of Elusive Polyps (DEEP2), using Fuji 7000 series colonoscopes (Fujifilm, Singapore). MethodsAn unblinded, randomized (1:1), controlled, prospective study was performed at a single ambulatory care endoscopy center under institutional review board approval. Included participants ages 40 to 85 years were scheduled to undergo colonoscopy for screening, surveillance, or symptoms. Exclusion criteria were inflammatory bowel…
Author: Praveen Suthrum
Dr. Camilleri: There are three really important points to make. The first is that the previous guideline from ACG was published in 2013—a decade ago (Am J Gastroenterol 2013;108[1]:18-37). The second is that there still is an unmet need in terms of diagnosis and treatment. And the third is that there’s interest in the guideline for gastroparesis, with the 2013 guideline being cited over 570 times. Although the European Society of Neurogastroenterology and Motility published a consensus document more recently (United Eur Gastroenterol J 2021;9[3]:287-306), it was based on expert opinion, in contrast to the rigor of the ACG guideline…
From TikTok to kombucha tea, gut health is having a moment – after we’ve already been hearing about it for years. Rightly so. Your gut – and its diverse mix of bacteria known as the microbiome – is no longer just about digestion. Gut “health” is also linked to the health of your heart, brain, immune system, and more. The problem: Much about what’s going in in there and what bacteria populate it at what levels – and how to interpret it all – remains a mystery. Studying the gut is tricky. Animal research may not be useful, because animals…
In the field of clinical research, one of the biggest hurdles can be finding eligible patients who are willing to actively participate in studies by taking time out of their lives over a period of months or years. While research providers have been working for years to address this problem, one innovative model has shown significant promise in improving the patient retention rate of clinical research: integrating research into existing private practices and making patient participation a natural extension of the care process with their provider. Participating in a clinical trial can have clear benefits for both a private practice…
People who have had COVID-19 have a 36% overall higher risk of developing gastrointestinal (GI) problems in the year after infection than people who have not had the illness, a large new study indicates. The researchers estimate that, so far, SARS-CoV-2 infections have contributed to more than 6 million new cases of GI disorders in the United States and 42 million new cases worldwide. The diagnoses more common among patients who’ve had COVID ranged from stomach upset to acute pancreatitis, say the researchers, led by Evan Xu, a data analyst at the Clinical Epidemiology Center, Research and Development Service, the…
Defensive strategies, such as denying immediacy of testing or exempting oneself, are key barriers to at-home colorectal cancer screening, according to study results published in Cancer. “Various emotional and attitudinal barriers to colorectal cancer screening participation, including fatalism, a fear of cancer, a desire to not know if one has cancer, disgust, embarrassment and beliefs that screening will be uncomfortable or inconvenient, have been identified,” Nicholas Clarke, PhD, a post-doctoral researcher in the School of Psychology at Dublin City University, and colleagues wrote. “Other potential emotional and behavioral responses are emerging but have received less attention; one example is defensive…
The smart toilet has the technology to interpret the data that’s dripped, dumped, or otherwise flushed to glean insights into health. Urine flow a bit light? That might indicate a problem with the prostate. Blood in the urine? That suggests a urinary tract or kidney infection. Different shapes and textures of waste can point to gastrointestinal problems. The smart toilet can even detect specific molecular signals that flag certain types of cancer or infectious diseases, such as COVID-19. There’s a lot of potential in the idea, even though its data source is something we think so little of. “Toileting habits…
Oshi Health, the virtual specialty care company transforming digestive health outcomes and economics, today announced that executives will be on hand at the American Telehealth Association’s 2023 Annual Conference & Expo as speakers and available to greet attendees at Booth 816-A in the IMPACT Pavilion in San Antonio, Texas on March 4-6, 2023. Throughout the event Oshi Health will share its innovative approach to virtual multidisciplinary care in gastroenterology (GI), including:
In episode five of Small Talk Big Topics, hosts Drs. Matthew Whitson and CS Tse are joined by guests Drs. Rena Yadlapati and Frank Scott to discuss how to become a clinical expert. First, the guests each share a brief introduction of themselves: Dr. Yadlapati is associate professor of medicine at the University of California San Diego, clinical expert in esophagology and medical director of the Center for Esophageal Diseases at UCSD; and Dr. Scott is an associate professor of medicine at University of Colorado, IBD specialist and clinical epidemiologist specializing in Markov models.
Amazon, CVS and other retailers have made big headlines in recent by acquiring companies and announcing partnerships to speed their push into healthcare delivery. The deals could transform the industry and the patient experience, but they could also be disastrous and highly-public failures. I’m rooting for the former, but unless corporate leaders step carefully I can easily see the latter taking shape. The difference-maker, I believe, will be whether these companies can essentially build a cultural and operational wall around their care-delivery divisions and assign gatekeepers who’ll turn away those who might infect those divisions with the typical corporate nonsense,…